Rupee rises 7 paise against US dollar in early trade
时间:2024-06-26 07:14:36 阅读(143)
The rupee was trading in a narrow range and appreciated by seven paise against the US dollar in early trade on Wednesday, amid a muted trend in domestic equities.
Forex traders said the rupee is trading in a narrow range as investors remain cautious ahead of the BRICS summit and US Federal Reserve Chair Jerome Powell’s speech at Jackson Hole Symposium this week.
On Tuesday, the rupee had recovered from its all-time low levels and settled higher by 14 paise at 82.99 against the US dollar.
“Market awaits with baited breadth the Jackson Hole Symposium between 24th and 26th in which Fed Chairperson’s speech will be keenly watched,” said Anil Kumar Bhansali, Head of Treasury and Executive Director, Finrex Treasury Advisors LLP.
Meanwhile, the dollar index, which gauges the greenback’s strength against a basket of six currencies, fell 0.08 to 103.48.
Brent crude futures, the global oil benchmark, rose 0.17 per cent to USD 84.17 per barrel.
In the domestic equity market, the 30-share BSE Sensex was trading 8.36 points or 0.01 per cent higher at 65,228.39. The broader NSE Nifty advanced 8.20 points or 0.04 per cent to 19,404.65.
Foreign Institutional Investors (FIIs) were net sellers in the capital markets on Tuesday as they offloaded shares worth Rs 495.17 crore, according to exchange data.
猜你喜欢
- Markets in a short term downtrend; sell Grasim, IRCTC to protect gains
- Market HIGHLIGHTS- Sensex ends 232 pts down, wipes off mild gains, Nifty at 18004 amid bulls & bears tussle
- Manufacturing activity at pre-covid levels, Capex, PLI to augment growth; check top stock picks
- Markets Ahead- Sensex, Nifty end mixed for second session; valuation drags, indices may trade flat in near term
- Management churn at Shoppers Stop leaves investors jittery
- YS Sharmila joins Congress, merges YSRTP ahead of 2024 Lok Sabha polls
- Markets in a short term uptrend; buy these two stocks to pocket short-term gains
- Market rally- Investors richer by over Rs 5
- Mankind Pharma share falls 6% today after gaining 32% over IPO price; should you buy, sell or hold-